• A Skeptic Converts: Tom Plasterer’s move from Big Pharma to AI Startup

    Bio-IT World | For more than a dozen years, Tom Plasterer has held roles at AstraZeneca both in research IT and in more science-facing positions including translational medicine. Along the way, he was beating the drum for FAIR data—data that are Findable, Accessible, Interoperable and Reusable— and knowledge graphs, playing an active role in both the FAIR community and the Pistoia Alliance.

    Aug 14, 2024

  • Safe and Intriguing ‘Nature’s Drugs’ Taking on Complex Diseases

    Bio-IT World | The cost of bringing a drug to market has, by some estimates, ballooned to $3 billion and the central problem could be the “misapplication of technology.” Since completion of the Human Genome Project, the focus had shifted heavily toward orphan drugs with a single genetic target, suitable only to highly targeted genetic technology platforms.

    Aug 13, 2024

  • Recursion, Exscientia Merge AI Drug Discovery Companies

    Bio-IT World | Recursion and Exscientia have entered into a definitive agreement to combine Recursion’s scaled biology exploration and translational capabilities with Exscientia’s precision chemistry design and small molecule automated synthesis capabilities.

    Aug 8, 2024

  • Singapore Launches Long-Read Population Sequencing Program with PacBio, Oxford Nanopore

    Bio-IT World | Singapore’s National Precision Medicine (NPM) program has launched a long-read sequencing project to gain deeper insights into Asian genetic diversity. The program, Precision Health Research, Singapore (PRECISE) has appointed both Oxford Nanopore Technologies (ONT) and PacBio (PacBio) to deliver sequencing.

    Aug 8, 2024

  • Howard Jacob on How AbbVie’s ARCH is Unlocking Major Opportunities

    Bio-IT World | At last year’s Bio-IT World Conference & Expo, AbbVie won an Innovative Practices Award for their AbbVie R&D Convergence Hub (ARCH). Their data platform is designed to provide access to knowledge in a faster and more automated way, as well as an easier way to extract insights and connect disparate datasets. Today, three years after the launch of ARCH, AbbVie has made great strides in data convergence with the platform.

    Aug 7, 2024

  • GE HealthCare, AWS Collaborate on Gen AI Models

    Bio-IT World | GE HealthCare and Amazon Web Services have announced a strategic collaboration to develop purpose-built foundation models and generative artificial intelligence (AI) applications designed to help clinicians improve medical diagnostics and patient care.

    Aug 6, 2024

  • BioTeam Acquired by British n2 Group

    Bio-IT World | BioTeam announced its acquisition today by British firm n2 Group. BioTeam will be a US-based, independent business within n2 Group. Financial details have not been disclosed.

    Aug 2, 2024